Kusajili – Centralise les essais cliniques mondiaux

Votre recherche

Pays: Russian Federation,Germany,France,Sweden - Phase: complete - Le promoteur: Sabina Rak, MD. PR

Sabina Rak, MD. PR MAJ Il y a 5 ans

Study of rBet v1 Tablets The purpose of this study is to determine the efficacy and safety of three doses of r Bet v1 administered as sublingual tablets in birch pollen allergic subjects.

Pays Denmark, Finland, France, Germany, Lithuania, Poland, Russian Federation, Sweden,
Organes Aucun
Spécialités Aucun

Essai clos aux inclusions

Plus d'informations

1